Welcome to Chronic Migraine Awareness, Inc.!
FDA APPROVES FIRST CGRP INHIBITOR FOR PREVENTION OF MIGRAINE ATTACKS
“For years the migraine community has been advocating for new treatment options that are specifically designed to treat migraine, a debilitating and often stigmatized disease. Today we celebrate the tireless work of researchers to better understand the biology of migraine and their ability to bring a new therapeutic approach to the millions of Americans who are seeking fewer migraine days. On behalf of the community, we would also like to thank the thousands of clinical trial patients whose unwavering commitment made this progress possible.”
-Kevin Lenaburg, Executive Director, CHAMP
Our mission is to be voice of the chronic migraine community. We are committed to empowering individuals to become their own advocates and alleviating migraine stigma by providing education and support to those whose lives are touched by this debilitating disorder.
Help us create awareness and support those with Chronic Migraine through Facebook Donate.